Ignite Creation Date:
2024-05-06 @ 3:25 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02283177
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2014-10-29
Brief Title:
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Organization Data
Organization:
Arog Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ARO-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arog Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None